Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics Market Cap

Heron Therapeutics has a market cap or net worth of $231.04 million as of February 6, 2026. Its market cap has decreased by -13.70% in one year.

• Market Cap: 231.04M
• Enterprise Value: 315.99M
• 1-Year Change: -13.70%
• Ranking: #3740
• Category: Micro-Cap
• Stock Price: $1.26

Market Cap Chart

Since December 1, 1998, Heron Therapeutics's market cap has increased from $127.40M to $231.04M, an increase of 81.35%. That is a compound annual growth rate of 2.21%.

Market Cap History

Date	Market Cap	% Change
Feb 6, 2026	231.00M	-3.10%
Dec 31, 2025	238.40M	2.45%
Dec 31, 2024	232.70M	-8.78%
Dec 29, 2023	255.10M	-14.17%
Dec 30, 2022	297.20M	-68.07%
Dec 31, 2021	930.70M	-51.60%
Dec 31, 2020	1.92B	-9.13%
Dec 31, 2019	2.12B	4.57%
Dec 31, 2018	2.02B	105.15%
Dec 29, 2017	986.50M	92.15%
Dec 30, 2016	513.40M	-46.54%
Dec 31, 2015	960.40M	227.11%
Dec 31, 2014	293.60M	110.32%
Dec 31, 2013	139.60M	-15.24%
Dec 31, 2012	164.70M	258.04%
Dec 30, 2011	46.00M	154.14%
Dec 31, 2010	18.10M	-63.51%
Dec 31, 2009	49.60M	281.54%
Dec 31, 2008	13.00M	-73.25%
Dec 31, 2007	48.60M	39.66%
Dec 29, 2006	34.80M	-10.08%
Dec 30, 2005	38.70M	-6.30%
Dec 31, 2004	41.30M	-18.22%
Dec 31, 2003	50.50M	146.34%
Dec 31, 2002	20.50M	-63.91%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Neurogene	272.00M
Nautilus Biotechnology	270.29M
Fennec Pharmaceuticals	270.15M
Coherus Oncology	268.33M
Enlivex Therapeutics	258.75M
OmniAb	254.80M
Cabaletta Bio	249.33M
Palisade Bio	247.35M